Company / SG&A Expense
Centene Corporation SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$12.9B
FY2025
5-year range
$9.6B / $12.9B
FY2021-FY2025
Trend
+4.1%
vs FY2024
Sector context
#6 of 158
Health Care
What the data says
Among 158 Health Care companies, Centene Corporation is in the bottom 4% for sg&a expense. Increased from $12.6B to $12.9B over the past 2 years.
Based on SEC 10-K filings.
$12.9B in FY2025 with a 5-year CAGR of +6.6%. Top quartile in the Health Care sector.
Increased from $12.6B to $12.9B over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +3.6%
- 5-Year CAGR
- +6.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 4% in Health CareTop 96% of 158This company $12.9B Sector average $175.9B
▼
-92.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.6%, indicating consistent growth.
- In FY2025, sg&a expense increased 4.1% year-over-year.
- Ranks #6 out of 158 companies in the Health Care sector.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.9B | +4.1% |
| FY2024 | $12.4B | -1.3% |
| FY2023 | $12.6B | +8.4% |
| FY2022 | $11.6B | +20.7% |
| FY2021 | $9.6B | +2.4% |
| FY2020 | $9.4B | +43.6% |
| FY2019 | $6.5B | +8.1% |
| FY2018 | $6.0B | +35.9% |
| FY2017 | $4.4B | +21.0% |
| FY2016 | $3.7B | +103.8% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026